The diagnostic work up of dementia may benefit from structured reporting of CT and/or MRI and the use of standardised visual rating scales. We advocate a more widespread use of standardised scales as part of the workflow in clinical and research evaluation of dementia. We propose routine clinical use of rating scales for medial temporal atrophy (MTA), global cortical atrophy (GCA) and white matter hyperintensities (WMH). These scales can be used for evaluation of both CT and MRI and are efficient in routine imaging assessment in dementia, and may improve the accuracy of diagnosis. Our review provides detailed imaging examples of rating increments in each of these scales and a separate teaching file. The radiologist should relate visual ratings to the clinical assessment and other biomarkers to assist the clinician in the diagnostic decision.
Introduction
The prevalence of dementia is increasing due to longer life expectancy, including a large increase of populations aged 80years and older. A thorough investigation of suspected dementia and pre-dementia stages is of high importance for early diagnosis, caretaking and, if possible, treatment. Brain imaging is included among the basic investigations in the work-up of dementia in many countries. Knowledge on dementia and particularly Alzheimer's disease has increased significantly in recent years, especially with regard to imaging methods and their impact on differential diagnosis. Nevertheless, this knowledge has not been fully implemented in clinical radiological routine work, most likely due to lack of communication between academia and clinical practice. In this paper,we describe how changes characteristic of common dementia disorders can be assessed in a structured way using computed tomography (CT) and magnetic resonance imaging (MRI).
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Established visual rating scores offer a practical, fast and inexpensive means of improving the diagnostic accuracy [1] .Our review is based on a collaboration between Karolinska Institutet, Uppsala University, Lund University, Gothenburg University and other university hospitals in Sweden, Norway and internationally as part of the imaging Fig. 1 cognitive impairment network (ICINET). ICINET was formed initially to standardise imaging dementia assessment, and recommend its use in clinical practice [2] . In normal ageing, cognitive functions may be reduced to varying degree, with pronounced reduction in some cognitive domains usually due to disease processeses leading to disability. Criteria for dementia are met if the disability becomes severe, affecting cognitive domains [3] . One of the most common causes of dementia is Alzheimer's disease (60-70 %). Hallmarks of the neurodegenerative process are abnormal production and/or reduced clearance of the beta amyloid (Aβ) protein which in its abnormal form is aggregated in so-called plaques [4, 5] . Phosphorylation of tau protein leading to degradation and destruction of cellular support structures is another important sign [6] . These changes in combination with other factors are most probably causing the extensive cell destruction that develops during the course of the disease that in its turn leads to cerebral atrophy of the brain, usually starting in the medial temporal lobes [7] [8] [9] [10] . Vascular dementia is another cause of cognitive impairment, considered to be the second most common form of dementia after Alzheimer's disease and is observed in about 30 % of all dementia patients. Recently, an overlap between Alzheimer's disease and vascular dementia with small vessel disease has been reported as a possible contributor and cause of dementia [11] [12] [13] . Cerebral amyloid angiopathy and hypertensive arteriopathy constitute the two most common small vessel diseases and are thought to be important parts of the dementia disease process [11, 12] . Other neurodegenerative diseases with cognitive impairment are frontotemporal dementia (2 % of all dementias [14] ) and Lewy body dementia (4.2 % of all diagnosed dementias [15] ). Cognitive impairment may also occur in, for example, depression and as a result of a brain tumour, cerebral haemorrhage and stroke.
The diagnosis of dementia is based on clinical symptoms as well as evidence of amyloid and tau pathology in the case of Alzheimer's disease [16] . MRI of the brain significantly increases the confidence of a dementia diagnosis. Traditionally, CT and MRI were used to rule out disease that may lead to cognitive impairment, such as for instance intracranial tumour and multiple sclerosis. However, in the modern clinical workup of dementia, CT and MRI are cornerstones due to their ability to detect patterns of atrophy that may be specific for a neurodegenerative disease, for example medial temporal lobe atrophy constitutes an early sign of Alzheimer's disease [17, 18] . In addition, imaging substrates of cerebrovascular disease are visualized and often the diagnosis of small vessel disease is added after CT and MRI. The European leukoariosis and disability (LADIS) studies have shown evidence that white matter hyperintensities increase the risk of cognitive decline (11) .
In order to maximize the yield of brain imaging in the clinical work-up of patients with cognitive impairment, it is important that imaging findings are reported consistently and according to established, validated rating scales [1, 19] . Here, we present a comprehensive overview of the most important findings on routine CT and MRI in dementia including visual scoring according to established rating scales. It should be emphasized that the assessment also can be performed on CT, which is still the most widely used modalility in routine dementia investigations. We suggest that these methods are incorporated into clinical protocols and are used for routine clinical image interpretation. Training to use the scales and available reference images is important for consistent accurate results of the visual evaluation [19] . Therefore we also provide image examples using the different rating scales (Figs. 1, 2, 3 and 4) and separate teaching material.
MRI protocol
Three basic MRI-sequences should preferebely used for the visual assessment : a T1-weighted 3D sequence to assess structural changes, a T2-weighted fluid attenuated inversion recovery (FLAIR) and a T2-weighted turbo spin echo sequence to detect other pathological changes, primarily white matter changes. We also propose the addition of a sequence for assessing microbleeds that could aid in the diagnosis of small vessel disease, preferably the susceptibility weighted imaging (SWI) sequence.
Structured assessment of CT and MRI
A structured radiological report with description of the imaging findings is required to provide optimal information to the referring clinician. The width of the sulci and the ventricles, the degree of medial temporal lobe atrophy, white matter changes and the occurrence of infarctions, mass effect or other changes, leading to secondary dementia, must be included. Comparison with previous radiological examinations is very important since relatively rapid progression of atrophy supports the suspicion of neurodegenerative dementia.
A radiological report should describe: 
Medial temporal lobe atrophy (MTA) -Scheltens scale
A rating scale for visual assessment of medial temporal atrophy (MTA) was developed by Philip Scheltens' research group in Amsterdam in 1992 [20, 21] . This scale has been used in a large number of studies and is also included in the research criteria for the diagnosis of Alzheimer's disease [22] . The height of the hippocampus, as well as the width of the temporal horns and choroid fissure are assessed on standardized coronal images.The assessment is conducted according to a five-point scale of 0-4, where MTA 0 and MTA 1 are considered normal. In MTA 0, the width of the choroid fissure and temporal horn, and the height of the hippocampal formation are normal; in MTA 1, only the width of the choroid fissure is slightly increased. MTA2-4 represent increasing degrees of atrophy. MTA 2 has increased width of the choroid fissure and temporal horn, and slightly decreased height of the hippocampus. MTA 2 is pathological in patients younger than 70 years of age. MTA 3 has severly increased width of the choroid fissure and temporal horn, and decreased height of the hippocampal formation. MTA 3 is pathological in all patients under 80 years of age. MTA 4 represents severe increase in width of the choroid fissure and temporal horn, and a severly decreased hippocampal height. MTA 4 must always be perceived as pathological, regardless of the patient's age ( Fig. 1 ) [23] .Several studies have investigated the cut-off for normal and pathological MTA as well as the effect of demographic variables, such as age, gender and education; average values of the left and the right side have been proposed [24, 25] . However average values may not be optimal for use in the clinical routine and more suited for research purposes. The MTA scale was originally developed for the assessment of MR images, but current high quality CT scans can also be used (Fig. 2) [26] . The MTA scale has demonstrated significant correlation with manual measurements of the hippocampus, and increased clinical relevance when seen in association with cognitive function [23] . The sensitivity and specificity are comparable to automated methods for volume measurement and calculations of volume of cortical thickness [27] . Inter-and intrarater reliability are very high in experienced raters, but may be slightly lower for raters if no prior consensus between raters has been established on cases [28] .
Global cortical atrophy -GCA Scale
The global cortical atrophy (GCA) scale was first developed by Pasquier et al. in 1996 for the purpose of assessing cerebral atrophy in patients with poststroke dementia [29] . The scale was subsequently further refined and adapted to enable quicker assessment in dementia [19] . Visual assessment of cortical atrophy reflects not only the degree of general cortical atrophy but also the degree of lobar and regional atrophy, which should be commented upon in the radiological report [30] . This is of particluar importance since atypical forms of AD are recognized with more frontal or posterior atrophy, rather than the temporal atrophy seen in more typical cases [31] .
Widening of sulci may be secondary to atrophy of the cortex and/or the white matter, why the term cortical atrophy in a strict meaning should only be used when the cortical thickness has been measured. Widening of sulci and gyral volume loss can be assessed using a 4-point scale, GCA 0-3 [32] . Normal sulci have GCA grade 0, slight widening of sulci classifies as GCA 1, gyral volume loss is categorized as GCA 2 and pronounced widening of sulci with severe volume loss, so called Bknife blade at-rophy^is labelled GCA 3 (Fig. 3) . Cortical atrophy can also be assessed with substansial agreement between CT and MRI [26] . Bifrontal GCA1 and biparietal GCA0. Note the wide lateral ventricles. f/ 11) GCA0. Some atrophy of one or two of the temporal gyri and widening of the Sylvian fissure, especially on the left side, GCA2. g/2) GCA1 in the parietal lobe. GCA1 and 2 in the frontal lobes. h/4) GCA1. GCA2 in the left side at the junction between the frontal and parietal lobes. i/5) GCA1-2, but mostly GCA2. j/16) GCA1 going towards GCA2. k/9) GCA1. Maybe atrophy in the frontal midsagital region with mild atrophy of the anterior cingulate gyri, GCA2? l/6) GCA2 m/13) BifrontalGCA1 and biparietal GCA2. n/20) GCA2, more atrophy left parietal. o/18) Bifrontal GCA2 and biparietal GCA1. p/19) GCA0 except for anterior gyri in both temporal lobes, GCA 2-3 left temporal and GCA1-2 right temporal. q/3) GCA2 in the left frontal lobe and GCA2-3 in the right. A few gyri with GCA3.GCA0-1 in the parietal lobes. Note the widening of the frontal horns of lateral ventricles and the atrophy of the anterior cingulate gyri. r/10) BifrontalGCA 2-3 and biparietal GCA0-1. Note atrophy of the cingulate gyrus and wide frontal horns. s/12) GCA3 in the temporal lobe on the left side. GCA1 on the right side and GCA2 in the cerebellum. t/15) GCA2 and maybe GCA3 in the Sylvian fissure. Biparietal GCA1. B. Global cortical atrophy (GCA) rating on CT.
Interpretation key. Numbers equal the corresponding image in the supplementary PDF file. a/1) GCA0 b/17) GCA0-1. c/5) GCA1. d/2) GCA1. e/8) GCA1. f/10) GCA1. g/18) GCA1 in the right hemisphere and GCA2 in left hemisphere. h/9) GCA1 in the more frontal part of the frontal lobes. GCA2 in general. i/19) In-between GCA1-2, but closer to GCA2. j/13) In-between GCA1-2, GCA2 bifrontal. Note the cavum septi pellucidi. k/3) Bifrontal GCA2 and biparietal GCA1.Note the wide frontal horns. l/6) Bifrontal GCA2, biparietal GCA1. m/7) GCA2 fronto-parietal. n/20) GCA2. o/16) GCA2, frontal lobe left.GCA1 in the right frontal lobe and GCA0 in the parietal lobes. Note the atrophy in the anterior cingulate gyri. p/11) Biparietal GCA2 and bifrontal GCA1. q/14) Another image of the same patient, GCA2. r/12) Note the side difference. GCA2 along the left hemisphere, GCA1 on the right side. s/15) GCA2 in supraorbital part of the frontal lobes and in the anterior part of the temporal lobes.GCA0 in the more posterior part of the temporal lobes. t/4) GCA3 in a few parietal gyri on the right side. Bifrontal GCA2 and GCA1 left parietal
White matter changes -Fazekas' scale
The Fazekas' scale was first constructed in 1987 in order to standardize the visual assessment of white matter changes seen on MRI. The scale has been used in a large number of publications on white matter changes and is included here because of its simplicity and applicability on CT and MRI, and we consequently recommend its use in the clinical dementia assessment. The Fazekas' scale includes assessment on axial T2-weighted or T2 FLAIR images for the whole brain and has four increments. Caps and bands, a rim of white matter hyperintensity around the ventricles, are seen as a normal finding in the brain. Grade 0 has no or occasional punctate white matter changes and grade 1 has multiple punctate white matter changes, which can be seen in all ages and is common in patients older than 65 years of age. The presence of a small number of such changes usually lack clinical significance. Grade 2 implies incipient confluence or bridging of punctate changes and grade 3 consists of confluent white matter changes. Grade 2 is regarded as pathological in patients younger than approximately 70 years of age, while grade 3 is always pathological (Fig. 4) . A modified version of the Fazekas' scale, the age related white matter changes (ARWMC) scale [33] includes analysis in further topographical regions.
Extended imaging assessment
Posterior atrophy -Koedam scale
The Koedam scale was developed 2011, to enable easy visual rating of posterior atrophy, that is atrophy of the parietal lobe including the precuneus, which may be a feature of Alzheimer's disease [34] . Posterior atrophy has been suggested to be of specific importance in patients with early Alzheimer's disease and no or minimal medial temporal atrophy [34] . Visual assessment is done in all three planesaxial, sagittal and coronal, with focus on the parietal cortex, the precuneus and the parietooccipital sulcus. The scale has 4 increments with 0 = no 
Small vessel disease -The STRIVE criteria
Markers of small vessel disease have become increasingly important for the evaluation of patients with dementia, and have been suggested to have a contributory as well as a causative role in the neurodegenerative disease process. The Bstandards for research into small vessel disease^were established in 2013 summarizing the scales and criteria and proposing a terminology to be used in the realm of small vessel disease imaging. Important small vessel disease markers are: 1. Cerebral microbleeds, seen as punctate foci of hypointensity on susceptibility sensitive sequences. The location of cerebral microbleeds is also of importance to mention in reports as deep bleeds represent underlying hypertensive arteriopathy, and lobar cerebral amyloid angiopathy. 2. Cortical superficial siderosis implies gyriform linear hypointensities that have been suggested to be a sensitive markers of cerebral amyloid angiopathy. 3. Lacunes and recent small subcortical infarcts are other terms that preferably should be used depending on imaging manifestations. Although white matter changes are part of the small vessel disease spectrum, they are discussed separately above.
Conclusion of the radiological report
Providing that the imaging has been conducted as part of a dementia investigation, a description of the findings, using the rating scales above, should be followed by an assessment of whether the findings are pathological or not taking the age of the patient into account. In addition, the radiologist should conclude if the described pattern could be consistent with the clinically suspected dementia disorder. Atrophy of the medial temporal lobes can support a clinical suspicion of Alzheimer's disease, especially if there is a progression Fig. 4 (continued) compared with previous imaging studies. It should, however, be noted that atrophy of the medial temporal lobes may also be found in other dementia disorders , e.g. Lewy Body Dementia and frontotemporal dementia. Vascular dementia can be considered unlikely if signs of cerebrovascular ischemia, strategical infarcts or microbleeds are missing. The final impression will thus provide a summary of the general imaging assessment, and also relate to clinical suspicion, and, if available, other examinations performed, such as a PET scan (e.g. glucose metabolism) or a SPECT (regional blood flow). This will improve the accuracy of the diagnosis of dementia disorders in clinical practice. 
